Integrity Implant System Post Market Clinical Follow-Up Study

Last updated: February 28, 2025
Sponsor: Anika Therapeutics, Inc.
Overall Status: Active - Recruiting

Phase

4

Condition

N/A

Treatment

Integrity Implant System

Clinical Study ID

NCT06741527
Protocol 24-01
  • Ages > 18
  • All Genders

Study Summary

The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

Eligibility Criteria

Inclusion

  1. At least 18 years of age

  2. Able (with assistance from LAR, if necessary) to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures.

  3. Able to complete all Patient Reported Outcome Measure (PROM) questionnaires.

  4. Fully understands study requirements and able to return for all required follow-up visits and assessments.

  5. Able to comply with all post-operative physician prescribed rehabilitation instructions.

  6. Index shoulder rotator cuff tendon tear surgical access may be performed using mini-open, single-portal arthroscopic or multi-portal arthroscopic intervention

  7. Meets all intended use and indications for use defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:

Index shoulder rotator cuff tendon tear needs management and protection from injury

Index shoulder has no substantial loss of tendon tissue

Index shoulder rotator cuff tendon tear footprint allows approximation of soft tissue and fixation of the Integrity Implant to tendon tissue using an Integrity Tissue Tack

Index shoulder rotator cuff tendon tear footprint allows fixation of the Integrity Implant to bone using the Integrity Bone Staple

Exclusion Criteria

The subject exclusion criteria are as follows:

  1. Medical condition that in the PI's opinion would place the subject at risk or interfere with the study

  2. Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study)

  3. Pregnant, breastfeeding, or plans to become pregnant during the study

  4. History of poor compliance with medical treatment of any kind

  5. Deemed contraindicated for MRI by the PI

  6. Previous rotator cuff surgery (any type) on the index shoulder

  7. Current instability of the index shoulder

  8. Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length >5cm)

  9. Chondromalacia of index shoulder ≥ Grade 3

  10. Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3

  11. Insulin dependent Type I Diabetes

  12. History of heavy smoking (≥ 1 pack per day) within last 6-months

  13. History of auto-immune or immunodeficiency disorders

  14. Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases)

  15. Oral steroid use in the last 2-months or injectable steroid use in the last 3-months

  16. History of cognitive or mental health status that interferes with study participation

  17. Poor comprehension of English language

  18. Meets one or more of the contraindications defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include:

18.1 Rotator cuff tendon tear is deemed irreparable by the PI

18.2 Rotator cuff tendon tear repair requires replacement of damaged tendon

18.3 Rotator cuff tendon tear repair requires fixation of soft tissue to adjoining soft tissue

18.4 Rotator cuff tendon tear repair requires tendon strength reinforcement

18.5 Presence of infection

18.6 Any condition which would limit the ability or willingness to restrict activities or follow directions during the healing period

18.7 Hypersensitivity to any of the Integrity Implant System components

18.8 Inadequate soft tissue support for Integrity Tissue Tack fixation

18.9 Inadequate quality of bone for Integrity Bone Staple fixation

Study Design

Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Integrity Implant System
Phase: 4
Study Start date:
February 01, 2025
Estimated Completion Date:
October 31, 2027

Study Description

The Study Objective is to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).

The clinical success will be evaluated by absence of rotator cuff re-tear. Performance and clinical benefits will be evaluated by functional outcomes measured using standard scoring systems such as the American Shoulder and Elbow Surgeons Shoulder Score (ASES), Constant-Murley Score (CMS), Patient Satisfaction, EQ-5D-5L, Single Assessment Numeric Evaluation (SANE), Visual Analogue Scale (VAS) and rotator cuff repair outcomes measured using MRI evaluation for repair integrity, quality, tendon tissue thickness and regeneration.

Safety of the Integrity Implant System will be assessed by monitoring the frequency and incidence of adverse events.

The Primary Endpoint shall confirm the Performance of the Integrity Implant System when used for rotator cuff augmentation (with or without repair). Performance will be evaluated by an adequately powered analysis of retear rates seen by MRI at 12-months after surgery.

Connect with a study center

  • Foundation for Orthopaedic Research and Education

    Tampa, Florida 33607
    United States

    Active - Recruiting

  • Central Indiana Orthopaedics

    Fishers, Indiana 46037
    United States

    Site Not Available

  • Norton Healthcare

    Louisville, Kentucky 40202
    United States

    Site Not Available

  • Towson Orthopaedic Associates/University of Maryland St. Joseph's Medical Center

    Towson, Maryland 21204
    United States

    Active - Recruiting

  • Virtua Health

    Marlton, New Jersey 08053
    United States

    Site Not Available

  • Steadman Hawkins Clinic of the Carolinas

    Greenville, South Carolina 29615
    United States

    Site Not Available

  • Campbell Clinic

    Germantown, Tennessee 38138
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.